By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

Post on 29-Mar-2015

220 views 0 download

Tags:

Transcript of By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.

By Dr. Olga Korosteleva

Today’s Talk:

Surviving Survival AnalysisBy Kelley Mizukami

OUTLINE

• What is Survival Analysis?• Censored Data• Kaplan-Meier Estimator• Log-Rank Test• Cox Regression Model

WHAT IS SURVIVAL ANALYSIS?

• Branch of statistics that focuses on time-to-event data and their analysis.

• Survival data deal with time until occurrence of any well-defined event.

• The outcome variable examined is the survival time (the time until the occurrence of the event).

• Special because it can incorporate information about censored data into analysis.

OBJECTIVES OF SURVIVAL ANALYSIS?

• Estimate probability that an individual surpasses some time-to-event for a group of individuals.– Ex) probability of surviving longer than two months until

second heart attach for a group of MI patients.• Compare time-to-event between two or more

groups.– Ex) Treatment vs placebo patients for a randomized

controlled trial.• Assess the relationship of covariates to time-to-

event.– Ex) Does weight, BP, sugar, height influence the survival

time for a group of patients?

SITUATIONS WHEN WE CAN USE SURVIVAL ANALYSIS

• We can use survival analysis when you wish to analyze survival times or “time-to-event” times

• “Time-to-Event” include:– Time to death– Time until response to a treatment– Time until relapse of a disease– Time until cancellation of service– Time until resumption of smoking by someone

who had quit– Time until certain percentage of weight loss

MORE EXAMPLES• Suppose you wish to analyze the time it takes for a

student to complete a series of classes. – Response /Status Variable: Time it takes to complete,

status– Predictor Variables: Age, Gender, Race, GPA

• Suppose you wish to analyze the time between admittance to the hospital until death for a lung cancer patient. – Response/Status Variables : Length-of-Follow up, status– Predictor Variables: Age, Gender, Race, White Blood

Counts, Tumor Type, Treatment Type, Cancerous Mass Size

MORE EXAMPLES• Suppose you are interested in comparing the time

until you lose 10% body weight on one of two exercise programs. – Response/Status Variables: Time it Takes, Status– Predictor Variables: Age, Gender, Starting Weight, BP,

BMI, Exercise Program

• Suppose you are interested in the time it takes before one sees results for a certain treatment.– Response/Status Variables: Time it Takes, Status– Predictor Variables: Age, Gender, Type of Treatment,

Weight, Height, exercise (Y/N), healthy eating (Y/N)

MORE EXAMPLES• Suppose you wish to compare the time it takes

before you cancel your cable TV service when you use two different cable providers.– Response/Status Variables: Time it Takes, Status– Predictor Variables: Age, Gender, Race, Cable Provider,

Average Income, Average number of complaints per month

DATA• Survival data can be one of two types:

– Complete Data– Censored Data

• Complete data – the value of each sample unit is observed or known.

• Censored data – the time to the event of interest may not be observed or the exact time is not known.

• We distinguish complete data from censored data by adding a “+” to any values that are censored. (i.e. 4+)

CENSORED DATA• Censored data can occur when:

– The event of interest is death, but the patient is still alive at the time of analysis.

– The individual was lost to follow-up without having the event of interest.

– The event of interest is death by cancer but the patient died of an unrelated cause, such as a car accident.

– The patient is dropped from the study without having experienced the event of interest due to a protocol violation.

• Even if an observation is censored we will still include it in our analysis.

FUNCTION DESCRIBING SURVIVAL TIMES

• is a random variable that represents survival time.

• The distribution of survival time can be described by the survival function.

SURVIVAL FUNCTION

• Let T denote the survival time, a random variable with the survival function:

Probability that a subject selected at random survives longer than time t.• Properties

– is bounded by 0 and 1, it is a probability– is a non-increasing function

SURVIVAL FUNCTION

• If there is no censoring, then a good estimator of , at time , is:

But usually there is censoring. Therefore we can estimate using the Kaplan-Meier estimator.

KAPLAN-MEIER ESTIMATOR

KAPLAN-MEIER (KM) ESTIMATOR

• Helps us find when there are censored data. • To find this KM estimator break up survival

probability into a sequence of conditions.• The probability of surviving or more years

from the beginning of the study is a product of observed survival rates.

KAPLAN-MEIER ESTIMATOR

: estimated by the proportion of people living through out of those who have survived beyond

: number at risk at : number who died at

- = number who survived beyond

HOW TO CALCULATE THE KM ESTIMATOR

EVENT TIMES (n=12): 2 3+ 5 6 7+ 10 15+ 16 16 27 30 32RECALL:

• Skip censoring points since they don’t change until we get to the next time point.

SURVIVAL CURVE

EXAMPLE DATA• The MYEL Data Set: Myelomatosis Patients

• The MYEL data set contains survival times for 25 patients diagnosed with myelomatosis (Peto et al., 1977). The patients were randomly assigned to two drug treatments. The variables are as follows:

• DUR is the time in days from the point of randomization to either death or censoring

• STATUS has a value of 1 if dead and a value of 0 if alive. » This tells is that the censored value will be 0 if the patient is alive and

1 or uncensored if they are dead

• TREAT specifies a value of 1 or 2 that corresponds to the two treatments.

• RENAL has a value of 1 if renal functioning was normal

WHAT DO THE DATA LOOK LIKE?

• Snapshot of the datadur status treat renal

8 1 1 1180 1 2 0632 1 2 0852 0 1 052 1 1 1

2240 0 2 0220 1 1 063 1 1 1

195 1 2 076 1 2 070 1 2 08 1 1 0

KM EXAMPLE USING SPSS

• Analyze > Survival > Kaplan Meier

• Time: Dur• Status: status(1)

– Here define 1 since it the value indicating event has occurred (i.e. death)

• Options: Check off survival plot

OUTPUT

OUTPUT

OUTPUT

LOG-RANK TEST

Comparing the survival curves of two treatment groups

LOG-RANK TEST

• Use the Log-Rank Test to compare the survival functions of two samples.

• H0: The two survival functions are the equivalent

• Ha: The two survival functions are different

TEST STATISTIC

• Test statistic:

• : Total observed deaths from group A• : Total expected deaths from group A

EXAMPLE USING SPSS

• Analyze > Survival > Kaplan Meier

• Time: dur• Status: status(1)

– Here define 1 since it the value indicating event has occurred (i.e. death).

• Factor: Treat• Options: Check off survival plot• Click on “Compare Factor” and choose “Log-Rank”

OUTPUT

OUTPUT

OUTPUT

COX REGRESSION MODEL

Incorporating Covariates

SURVIVAL MODELS

• Models that relate the time that passes before some event occurs to one or more covariates that may be associated with that amount of time.

COX REGRESSION MODEL

• This model produces a survival function that predicts the probability that an event has occurred at a given time t, for given predictor variables (covariates).

COX REGRESSION MODEL

• is the time• are the covariates for the individual• is the baseline hazard function. This is the

function when all the covariates equal to zero.

HAZARD FUNCTION

• The hazard function:

This is the risk of failure immediately after time given they have survived past time t.

INTERPRETATION OF THE BETAS

• First we need to find the ratio when there is a one unit increase in the covariate, provided the other covariates stay fixed.

• We interpret as the increase in log hazard per unit of

EXAMPLE USING SPSS• Analyze > Survival > Cox Regression• SPSS fits the model with minus beta

coefficients: It has to be taken into account when interpreting the coefficients

• Time: Dur• Status: status(1)

– Censoring value: 1• Covariates: treat, renal

– Categorical: treat, renal

OUTPUT

OUTPUT

Interpretation:• The hazard for patients receiving treatment 2

is 28.8% of that for treatment 1 patients. • Patients with normal renal function have 1.6%

hazard as compared to those whose renal function is abnormal.

42